PDT PDT
Company Profile ↓Company Overview
PDT (PDT) is a publicly traded company listed on with a market capitalization of $579.40M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 2.9.
Maintains a net profit margin of 97.1%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Oct 2025 Revenue of $70.49M (-64.5% YoY); net profit $68.47M.
- Trailing 12 Months Year-on-year growth — revenue -64.5%, earnings -65.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -64.45% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -65.17% |
Stock Price Performance
| 1 Year: | -2.66% |
| 6 Months: | -5.79% |
| 3 Months: | -7.06% |
| 1 Month: | +0.15% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)44.97 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 97.1%.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue | - | -52.88M | -42.95M | 198.30M | 70.49M |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 1.70M | 1.72M | 1.73M | 2.02M |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 7.04M | 20.89M | 22.65M | 19.09M |
| Pretax Income | - | -54.58M | -44.67M | 196.58M | 68.47M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -54.58M | -44.67M | 196.58M | 68.47M |
| Diluted EPS | 3.23 | -1.11 | -0.91 | 4.00 | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 994.03M | 898.20M | 1.04B | 1.06B |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | 134.68K | 129.64K | - | - | - |
| Inventory | - | - | - | - | - |
| Receivables | - | 5.40M | 13.88M | 8.94M | 6.15M |
| Total Liabilities | - | 375.39M | 377.60M | 375.85M | 375.76M |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 373.70M | 373.70M | 373.70M | 373.70M |
| Total Equity | - | 618.64M | 520.60M | 668.48M | 688.26M |
| Shares Outstanding | - | 49.09M | 49.19M | 49.19M | 49.19M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 52.93M | 53.03M | 48.69M | 48.55M |
| Investing Cash Flow | - | - | - | - |
| Financing Cash Flow | -52.93M | -53.16M | -48.69M | -48.55M |
| Capital Expenditure | - | - | - | - |
| Free Cash Flow | 52.93M | 53.03M | 48.69M | 48.55M |
| Net Change in Cash | -5.05K | -129.64K | 0 | 0 |
Ratios (Annual)
Figures in %.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 103.2% | 104.0% | 99.1% | 97.1% |
| ROE % | - | -8.8% | -8.6% | 29.4% | 9.9% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PDT
John Hancock Premium Dividend Fund (NYSE:PDT) Reaches New 52-Week Low - Time to Sell? - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxPTE5rUHVZYnJRY2s1bHBJUjZuLWVvVllub2R4bVBYVEpUVjA4OFc2NjFESE5ndVBpcW5JTlNlZko5WHhHdzBtUXFZb3JLV1Rtd1BHQm9ZVGVndFVqTVNLSDI2NXhXWUhDN1BhM092ZnZpbEd1aXlQeXN6VXdVVENtQ0hxMHNoVmpDd0lxYV…
The End of the PDT Rule Changes the Futures vs. Stocks Debate - tastylive
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNZWd4Nk5uYXVGM2FLUWo2My1hc1NkVHhlenF4U2JKSi0yMWI5NHg0VERORzdqUm52d3YxWGx6NjFHZlBuc3VDRWlfLUhnMWwtUHBNbWV6elNndndCcVRkc3BmMk40bGw4UzFaOXRqVnVHNndIYTNsUFEtS1U4Q2d4R245cldDTEYzRUctRm…
The PDT Rule Is On Its Way Out: 5 Stocks That Stand to Benefit the Most - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxOeFVLZzBYLUg1cXZmZE5DVXotZl9BczRNeUNaU253c1hiNVNXa3ZFZXhvZmpDMmxYWE9nRGsyZExmMXV1SXdWRk1BZmtfRzNSNlAzeGtWVTdHZjJaRVEtOGk3dnNDSFFfckFzY3FoclltVDNIRVVSellHb1UzdlRlRTJiNVFMM3VlTXZOdy…
What to Know About the Demise of the Much-Hated ‘PDT’ Trading Rule - WSJ
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOb0FpRkN2N09UV042VTZkcUhYX2xSMnp5R2R2Smhkb0E3TEc2SVpHeDFPcGlPNFc5Wjdhc3VBZngwYzhaRkJpYl9ZWW1XdjFJTnZCWFVGQl9iTE5GdHVkRl9aVDhHS0VPNlBualNjWkRtSE5FaTY1VTYwTzJ5T0plbVFaYU5BRXB0UTNoWG…
PDT: Hard To Recommend For Income Investors (Rating Downgrade) (NYSE:PDT) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNQUNWYU1fR0NXT0lBZkxPUkpkOVR1WDBCei1nZUFFMVFfXzdEWG5EUGNuVDA2eURSaTk5MHpHSVBIQXAzb0k4REhxcHJtZUR4LVpqUk1CRnRsQmZvYXFxZEJZLVg5dnZoRWRER3E4WmlBdmJXQXVFTUpRMHhLb3RyU25vOWE4VXZWSHVSaV…
From Acne to Skin Cancer, PDT Finds Expanding Role in Dermatology - AJMC
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQT2NkaEl1RVJUaWtNX1J2SHFlXzJtZjhaSml1LXpndDB0X1dxdzREZUNxU2hxekprNlljMzlQcjJveHd6MldZMFY1UjhfZDJrcEg2Uzc0MVlHZHZNMzcwWngxYURHQTB5X2hvTTc0QU1yWTdHQmZrMUFLd3oxODNOcndrdEh1VEFXeHhFOE…
PDT — Frequently Asked Questions
What is the current share price of PDT?
As of 2026-10-23 16:27 PDT, PDT trades at $11.78 on NASDAQ/NYSE. Its 52-week range is $11.49 to $12.87.
What is the market capitalisation of PDT?
PDT has a market capitalisation of $579.40M on NASDAQ/NYSE.
What is the P/E ratio of PDT?
PDT trades at a trailing price-to-earnings (P/E) ratio of 2.94. Its price-to-book (P/B) ratio is 0.84.
What is the return on equity (ROE) of PDT?
PDT has a return on equity (ROE) of 9.95%.
Is PDT a good stock to buy?
This page provides a data-driven analysis of PDT, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.